GlaxoSmithKline has kicked off a Phase III trial assessing its lupus drug Benlysta in combination with rituximab in adult patients with the condition. More: GSK trials Benlysta/rituximab combo for lupus Source: News
read moreSeattle Genetics officially has the first-line Adcetris nod in advanced classical Hodgkin lymphoma that it’s been gunning for. Now, it’ll be up to the company to capitalize on what CEO Clay Siegall has called “the biggest market opportunity that we
read moreAMPAC Fine Chemicals (AFC) recently registered a Virginia plant with the DEA to make controlled substance APIs, and Noramco says it will tap that facility for the extra capacity it needs for its growing business producing scheduled drugs for its
read moreNovartis sales reps and doctors plan to testify in a long-running kickbacks case, court filings show, as prosecutors marshal evidence they say will show the company traded fancy dinners and entertainment—and in some cases, jobs for physicians’ relatives—to increase prescription
read moreRetirement was short-lived for former Eli Lilly CFO Derica Rice, who’s now planning to head up a pharmacy benefit manager. And his move to CVS Caremark follows just a week after UnitedHealth’s Optum unit said former GSK chief Andrew Witty
read moreGlaxoSmithKline’s new CEO Emma Walmsley isn’t the only one shaking things up at the top of the British drugmaker. Luke Miels, Walmsley’s pick to head the pharma division, has tasked his managers with finding budget savings of 20% to put
read more© 1994 - 2026 B.M. Pharmaceuticals